Safety Assurance Awaits Further Data for New Psoriasis Drugs - Skin and Allergy News Digital Network

Skin and hypersensitivity reaction News Digital Network status Assurance Awaits Further collection for New Psoriasis Drugs Skin and Allergy tidings Digital Network LAS VEGAS – New agents for treating psoriasis have shown great promise in status of efficacy, but assurances of safety await more data from larger studies. Thus far, phase 2 data show impressive effectiveness and no worrisome status signals for the ... Link To Article